Rina Das Eiden, PhD, senior research scientist in the University at Buffalo Research Institute on Addictions, has been invited to serve on a National Institutes of Health review panel.
BUFFALO, N.Y. -- Amy Gancarz, PhD, a postdoctoral associate in the University at Buffalo Research Institute on Addictions (RIA), was honored for her work during the Seventh Annual Neuroscience Research Day held at UB’s Clinical and Translational Research Center on Sept. 27.
BUFFALO, N.Y. – Bright Buffalo Niagara, Western New York’s premier venture forum, gave 34 high-tech companies from across the region and beyond the chance to pitch their companies to investors and business leaders on Tuesday, Oct. 1. Entrepreneurs presented in one-minute or 10-minute sessions to potential investors with the goal of garnering new support and investments.
BUFFALO, N.Y. – Bright Buffalo Niagara, Western New York’s premier venture forum, will feature 35 promising young companies in the life sciences, energy, software and other high-tech industries who will pitch to potential investors in 10-minute or one-minute sessions.
BUFFALO, N.Y. – Cocaine and brain function. Susceptibility to alcoholism. Smoking and schizophrenia. Marijuana and stress. Dozens of research scientists from across New York State will discuss these issues and more at a neuroscience conference to be held Sept. 27-28 at the University at Buffalo Research Institute on Addictions (RIA), 1021 Main St., Buffalo.
BUFFALO, N.Y. – Following the recent cancellation of a music festival due to fatal overdoses of the club drug “Molly,” the University at Buffalo Research Institute on Addictions (RIA) has released another in its series of expert summaries to educate the public on this latest drug trend.
BUFFALO, N.Y. – Thanks to efforts like the Human Genome Project, scientists are unraveling the role that genes play in the development of diseases such as cancer and Alzheimer’s.
BUFFALO, N.Y. -- Gerard Connors, PhD, senior research scientist and former director of the University at Buffalo’s Research Institute on Addictions, was recently recognized for his exemplary mentorship of promising scientists with a national award from the American Psychological Association’s Society of Addiction Psychology (SoAP).
BUFFALO, N.Y. – More children with juvenile rheumatoid arthritis are experiencing remission of their symptoms, thanks to new biological therapies, but the remission is not well-understood. A new study published today in Arthritis Research & Therapy provides the first genomic characterization of remission in juvenile rheumatoid arthritis patients.